Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis, is effective against RA, according to a new review. The review examines recent trials to assess safety and efficacy of the drug.
Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis, is effective against RA, according to a new review. The review examines recent trials to assess safety and efficacy of the drug.